Drugs / AWZ1066S
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05084560 | Dec 2021 → May 2023 | onchocerciasis | Liverpool School of Tropical Medicine | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AWZ1066S | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05084560 ↗ |
| Modality | Small molecule | “Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug” NCT05084560 ↗ |
| Route | Oral | “healthy adults received a single oral dose of AWZ1066S” PMID 38924387 ↗ Jun 2024 |